Daniel Long’s Septerna Insider Trades: Buying Low, Selling High Amid Growing Confidence
Daniel Long’s insider trades reveal a mix of strategic buying and high‑price selling, signaling confidence in Septerna’s drug‑discovery pipeline and hinting at possible upcoming liquidity events.
3 minutes to read